Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am still confused though. You mention what has been posted by others here - you are the main person posting about the terrible state of the company. And now the lawyers have confirmed your views - no assets and no income stream and laughable IP. So basically, as you have often said here, it will soon be time to turn the lights out.
There is an incredible amount of previous litigation over the years, which has cost me a small fortune to download from Pacer etc. The content is so rich that basically they should write a book or sell the movie rights. I am no lawyer myself but basically I believe where matters stand are as follows:
Montano has won an arbitration award of $900k less $50k set-off. Plus some costs. This is for back wages in the period when Montano and team were still trying to keep the lights on themselves and spending the lifeline funding provided by Wallen. Sadly they didn’t succeed in keeping the company afloat, and the loans and funding extended by Wallen, which were underpinned by Personal Guarantees issued by Montano to Wallen, were called in. Montano obviously couldn’t pay back and eventually, after an extended legal tussle, Wallen won control of the Board through a shareholder vote majority and the Montano faction was removed.
This particular story has played out countless times over the years. The detail of the extended litigation and arbitration is ‘a good read’ but ultimately things are what they are. And what are they?
Montano wants his back wages awarded by the arbitration award paid to him. And Wallen wants the money he provided to try keeping the company afloat when Montano was earning those ‘back wages’ repaid. In my mind, our next litigation instalment will be all about whether the Personal Guarantees provided by Montano were fair and reasonable given the then circumstances. No doubt Dan will challenge and Calvin will defend - but at some point in time, in order for Calvin to collect on the personal guarantees, Calvin will have to attack and Dan will need to do some defending of his own.
Others here are saying the personal guarantee amount due Wallen is $2.5m - I haven’t had time to look back through all the historical Court transcripts yet, but give me time.
Maybe the Arbitrator was a clever guy in awarding Dan such a high amount for ‘back wages’ of around 900k for a 2 year period. He acknowledges that Dan was at significant personal risk as a result of the personal guarantees he provided to Calvin at that time, and was therefore highly motivated to work hard for himself and the company in order to ensure the PGs were never exercised.
Ultimately though Dan again failed in these efforts which sadly for him is a recurring and consistent trend. But it does leave the onlooking shareholders with a potential ‘thrilling final chapter’ in this painfully long running saga.
CVBT/VT's lawyer stated that the company was worthless in late April of 2021. Posts like this, among others, seem to be promoting the stock in mid-May despite the fact that company administrators must have known of the lawyer's statement of fact. Since this post was made after administrators knew that the company had zero value, according to their lawyer and found in US Federal Court records, does that mean that administrators such as Grant Gordon have knowingly committed fraud? Are other administrators such as Mike Flaa and Calvin Wallen III also responsible for committing fraud by attempting to promote the stock knowing that the US Federal Court records state that the company had no value?
You would have to ask Dan Montano why he is doing what he is doing, I can't say. But based on what I've read here posted by others, I suspect the reason why Dan is pursuing the company's assets to liquidate them (even if they are worthless) is because he's required to do this first in order to then pursue the officers and directors personally and their insurance company if there is one to collect his judgment. I'm not a lawyer nor am I involved, but if I understand correctly, actions taken by the officers and directors throughout this extended ordeal have created personal liability that allows for the piercing of the corporate veil. But I believe that first Montano is required to collect what he can from the company before he goes after the individuals.
CVBT/VT LAWYERS ADMIT CVBT/VT IS WORTHLESS IN FEDERAL COURT
The truth about Cardiovascular Biotherapeutics/Venturis Therapeutics is coming out as a result of the lawsuit they have filed against our former administration.
Our own lawyers were forced to withdraw themselves from the case as a result of Cardiovascular Biotherapeutics'/Venturis Therapeutics' inability to pay the company's lawyers.
As bad as that may sound, this is not all, the company's lawyer then went on to state: Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
Our own lawyers admitted in Federal District Court the incompetence of our administration. We are a worthless company. The United States Federal Court states it in their records, our own lawyers state it, our former administrative members say it.
Cardiovascular Biotherapeutics/Venturis Therapeutics is officially worthless.
I am a bit confused Walhall. If Cannaday says the patents are worthless, why then would Montano want to spend lots more cash seizing control of them? Especially if, as you say in your post, they are ‘laughable to begin with to anybody outside this company’.
Whatever happened to the so-called "valuable" patents, Venturis supporters? (Obviously they were laughable to begin with to anyone outside this company who knows the first thing about biotechnology.) Once Dan Montano seizes them and the rest of the assets he is reportedly in the process of seizing, it will be interesting what their real value actually is.
As it is, Venturis' lawyer Barry Canaday has already passed judgement on the value of those patents. His direct quote: "Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made."
Yes, a sad state of affairs this. Dan is lucky then his shares were taken from him and put into estate upon bankruptcy when having some value. Any left now would be totally worthless. And he doesn’t get his 900k either. He has been really unlucky with his CVBT association.
THE END: The revealing declaration from Venturis's lawyer:
So many lies have been promoted in public by anonymous pro-company individuals about Venturis Therapeutics. This declaration by Venturis Therapeutics's own lawyer, withdrawing from representation on April 12, 2021, puts every last one of them to rest. Here it is in its entirety:
DECLARATION OF BARRY F. CANNADAY IN SUPPORT OF MOTION TO WITHDRAW
I, Barry F. Cannaday, declare as follows in support of this Motion to Withdraw as an Attorney for Venturis Therapeutics, Inc. (“Venturis”) in the matter styled Daniel C. Montano and Dr. John W. Jacobs vs. Venturis Therapeutics, Inc., Case No. 2:20-cv-01410-GMN-BNW originally filed in the United States District Court for the District of Nevada, but which was closed on January 21, 2021 (the “Previously Closed Case”):
1. I am an attorney duly licensed to practice before all Courts in the State of Texas and I was admitted to practice Pro Hac Vice in the Previously Closed Case on behalf of Venturis on August 18, 2020. I have been a partner in the law firm of Dentons US, LLP since 2009.
2. Venturis initially agreed to retain Barry F. Cannaday in connection with the arbitration that was filed by Venturis against Mr. Montano and Dr. Jacobs (“Counter-Claimants”) on July 19, 2018. Following the issuance of the Arbitrator’s Final Award in that Arbitration on July 20, 2020, Counter-Claimants filed an Application for Order Confirming Arbitration Award in this Court on July 29, 2020. Barry F. Cannaday agreed to continue to represent Venturis in connection with the proceedings in this Court relating to Counter-Claimants attempts to confirm the Arbitration Award. This Court confirmed the Arbitration Award on January 25, 2021 and this case was thereafter closed on January 25, 2021.
3. On April 8, 2021 counsel for Counter-Claimants provided Barry F. Cannaday with copies of post-judgment Interrogatories and Requests for Production,. However, Barry F. Cannaday has not agreed to represent Venturis in any connection with post-judgment collection matters. Mr. Cannaday considered his representation of Venturis in this matter completed when this case was closed on January 25, 2021.
4. Further, as of March 31, 2021, Venturis owed Mr. Cannaday’s law firm, Dentons US LLP (“Dentons”), unpaid fees in excess of $200,000 for representation in this Previously Closed Case and for representation in the underlying arbitration.
5. Barry F. Cannaday performed his obligations as counsel for Venturis in the Previously Closed Case and in the underlying Arbitration in a skillful and diligent manner. However, Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement.
6. Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
7. Barry F. Cannaday and Venturis have maintained a good working relationship throughout these proceedings. As such, the present Motion to Withdraw is not the result of any differences between Barry F. Cannaday and the client, but instead is the result of the inability of Venturis to meet its financial obligations to Dentons.
8. Defendant’s address is: 10455 Markison Road, Dallas, Texas 75238 and Barry F. Cannaday certifies that Venturis will be served with a copy of this Motion to Withdraw.
9. I personally visited with Jon Ross, Secretary and a Member of the Board of Directors of Venturis on Thursday, April 8, 2021 and advised him of my intention to file this notice and motion. Mr. Ross stated that Venturis had no objection to this Motion to Withdraw. I declare under penalty of perjury of the laws of the State of Nevada that the foregoing is true and correct.
Executed this 12th day of April, 2021.
/s/ Barry F. Cannaday
Barry, F. Cannaday, Esq.
DENTONS US LLP
2000 McKinney Ave
Suite 1900
Dallas, Texas 75201
Telephone: (214) 259-1855
Facsimile: (214) 259-0910
So this is it, folks. Venturis's own lawyers says that the company has only worthless assets and no revenues, and that they've stiffed his firm to a figure north of $200,000. We'll discuss the implications of this declaration in the future, but right now, I believe this is the final word on this dead company, led to its demise in my opinion by crooks and charlatans, all of them.
CVBT/VT LAWYERS ADMIT CVBT/VT IS WORTHLESS IN FEDERAL COURT
The truth about Cardiovascular Biotherapeutics/Venturis Therapeutics is coming out as a result of the lawsuit they have filed against our former administration.
Our own lawyers were forced to withdraw themselves from the case as a result of Cardiovascular Biotherapeutics'/Venturis Therapeutics' inability to pay the company's lawyers.
As bad as that may sound, this is not all, the company's lawyer then went on to state: Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
Our own lawyers admitted in Federal District Court the incompetence of our administration. We are a worthless company. The United States Federal Court states it in their records, our own lawyers state it, our former administrative members say it.
Cardiovascular Biotherapeutics/Venturis Therapeutics is officially worthless.
Waiting for Montano's 1.4 million judgement.
CVBT/VT LAWYERS ADMIT CVBT/VT IS WORTHLESS IN FEDERAL COURT
The truth about Cardiovascular Biotherapeutics/Venturis Therapeutics is coming out as a result of the lawsuit they have filed against our former administration.
Our own lawyers were forced to withdraw themselves from the case as a result of Cardiovascular Biotherapeutics'/Venturis Therapeutics' inability to pay the company's lawyers.
As bad as that may sound, this is not all, the company's lawyer then went on to state: Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
Our own lawyers admitted in Federal District Court the incompetence of our administration. We are a worthless company. The United States Federal Court states it in their records, our own lawyers state it, our former administrative members say it.
Cardiovascular Biotherapeutics/Venturis Therapeutics is officially worthless.
"it has become evident that there are currently no assets or revenue streams from which payments can be made."
It gets worse. Not only did our company's lawyers withdraw themselves from Cardiovascular Biotherapeutics/Venturis Therapeutics' lawsuit in federal court, they have also emphasized how defunct Venturis Therapeutics/CVBT truly is in a statement to the United States Federal Court. I have posted another excerpt:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 23-25 read as follows:
"Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made."
"...unpaid fees in excess of $200,000..."
I was able to get my hands on some court documents and was able to find more about why CVBT/VT's lawyers have withdrawn themselves from their suit in Federal District Court. It appears that we did not have enough money to pay them. I have posted an excerpt here:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 15-17 are as follows:
Further, as of March 31, 2021, Venturis owed Mr. Cannaday’s law firm, Dentons US LLP (“Dentons”), unpaid fees in excess of $200,000 for representation in this Previously Closed Case and for representation in the underlying arbitration.
"Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement."
I have managed to obtain some court documents further ellaborating why our company's lawyer has withdrawn himself from the case. I have posted an excerpt here:
UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC.,
formerly known as CARDIOVASCULAR
BIOTHERAPEUTICS, INC.
Claimant,
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN
THE ALTERNATIVE, MOTION TO
WITHDRAW AS COUNSEL FOR
VENTURIS THERAPEUTICS, INC.
Page 3, Line 16 Reads as follows:
However, Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement.
If I’m reading this correctly, CVBT/VT’s lawyers have withdrawn themselves from the cases? Please correct me if I am wrong.
This must be bad news for CVBT/VT
Anyone got a comment on this?
https://www.pacermonitor.com/public/case/35572685/Montano_et_al_v_Venturis_Therapeutics,_Inc
This looks like the debtor request and the counter suit. Can anyone confirm?
https://www.pacermonitor.com/public/case/39286223/Venturis_Therapeutics_Inc_v_Montano_et_al
Venturis Therapeutics shareholders shafted again, 2021 version
Its now 2 years running that the leadership of Venturis Therapeutics (formerly Cardiovascular Biotherapeutics), the insolvent, illiquid, zombie company, has shafted us shareholders by not holding the annual shareholders meeting as required by the company's bylaws and by the written promises of Calvin Wallen III, the Chairman and CEO. The shareholders meeting was supposed to occur in May 2021 right about now, and obviously is not happening. Nor did it happen in May 2020. The leadership of this company acts as if nothing is wrong with that, or anything else.
Why is the company not delivering on this most basic of promises?
Why has the company not run a single clinical trial since 2007 and why are the company's supporters promoting The Big Lie that it actually is?: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163681691
Why has most everything that Calvin Wallen told us at previous shareholder meetings with regards to capital raising, re-starting clinical trials, etc. never come true? Is it possible for any CEO to have less credibility than Mr. Wallen? And why are the directors doing nothing about all of this?
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157492465
I think it is $1,700,000 that Conman owes VT. $2,500,000 less the back pay of $800,000.
Imagine being awarded back pay for almost bankrupting the company. As I understand it neither Calvin or Grant take any pay for building VT into a real biotech corp.
Tears of a sad clown
There is no way Dan Montano can repay $2,500,000.
Again, contact Grant Gordon. It has the patent information in the presentation. From memory I think it is now 12 and counting. Also, I think there is something in order of 40 pending patents. A stark comparison of Montano's 0,000,000,000 patents*
*Dan Montano is the only person in pharma/biotech who believes you don't need patents.
My PDF copy is way out of date. Email Grant Gordon on ggordon@venturistherapeutics.com & he can give you an up to date version (I think)
I cannot find a copy of the Venturis corporate presentation on the www.venturistherapeutics.com website. Does anyone have a copy of it they could share?
Does anyone know how many patents Venturis has under its belt?
$2,500,000 owed to Venturis.
If Dan Montano is bankrupt (financially & morally) how can he possibly repay $2,500,000?
Thanks APDP. So, good it's worth reading again.
apdp Saturday, 05/15/21 03:56:28 AM
Re: SlalomKing post# 3068 0
Post #
3069
of 3086
And that is the bottom line. Funny how no one could dispute my earlier post: Here is a link that is hard to dispute: https://uploads-ssl.webflow.com/5d929ea754fd0f4955087956/608c36b4f0b7c7ffa9bb6319_CAD%20patent%20PR%20final%204.29.2021.pdf
Evidently many are buying into Montano's clones promoting his new company. Hopefully they buy his IPO to satisfy his debt to Venturis.
CEO, Calvin Wallen, has assigned his $2,500,000 court judgement to VT which means that VT is now going after Dan Montano for the balance they are owed of $1,700,000.
Parents should pay particular attention to the fact that their children could be in pearl due to Conman's proclivity of driving through parking lots full of soccer moms and their kids at 50+ MPH.
Refer to the Worst CEO Ever YT video.
APDP its actually $1,700,000 that Conman owes VT.
A few years ago an adverse decision in the Nevada courts awarded Calvin Wallen $2,500,000 against Conman Dan. An arbiration case awarded Conman $800,000 of back pay. The balance of $1,700,000 is now being pursued by VT aggressively.
Poor Old Conman, he simply can't catch a break
He pushed most off the early players away, Stegman, Mike N, Mike F. Ken T, Seth H etc.
They knew he was greedy, blew the whole thing.
This (CVBT) should have happened 12 years ago
Yeah right, he could not even sell lumber to a builder right now.
He's very upset you can see his frustration in his graphite.
He knows the end is near.
Those CVBT patents will cash in big time soon.
Now Montano only owes Venturis 1.4 Mill. Buy his IPO and Venturis gets paid.
$1,100,000 awarded to Daniel C. Montano by the US Federal Court against CVBT/VT
The United States Federal court has confirmed Daniel C. Montano's $1.1 million dollar judgement against CVBT/VT as a result of their fraudulent and frivolous lawsuit claiming that Daniel C. Montano's IP was not his.
The US Federal Court not only confirmed that Daniel C. Montano has a $1 million dollar (non-off-settable) judgement against CVBT/VT, but that Daniel C. Montano and Zhittya Genesis Medicine own all of their IP.
Daniel C. Montano announces that the US Federal Court has confirmed his IP
The United States Federal Court has confirmed the ruling in favor of Daniel C. Montano citing that Dan Montano owns all of the IP that he and his company, Zhittya Genesis Medicine are developing.
The United States Federal Court's confirmation comes as a result of Cardiovascular Biotherapeutics/ Venturis Therapeutics' own management team testifying in favor of Daniel C. Montano, stating that the IP that Dan Montano and Zhittya Genesis Medicine have been developing are 100% theirs.
Daniel C. Montano Announces His Victory over CVBT/VT
Despite years of fraudulent and frivolous lawsuits it appears that Daniel C. Montano is now victorious over the crooks that run Cardiovascular Biotherapeutics/Venturis Therapeutics.
Daniel C. Montano has been awarded an over $1 million dollar judgment against CVBT/VT as a result of the frivolous lawsuit that they had originally filed.
Daniel C. Montano's more than $1,000,000 dollar judgement against Cardiovascular BioTherapeutics/Venturis Therapeutics has been confirmed by the United States Federal Court System.
Dan Montano's clear victory over CVBT/VT could result in a forced debtors exam against CVBT/VT in order for Montano to collect on his judgement.
Daniel C. Montano has announced that he has won a $1 million dollar judgement against CVBT
Daniel C. Montano has announced that he has won a $1 million dollar judgement against Cardiovascular Biotherapeutics/Venturis Therapeutics confirmed by the US Federal Court. The judge dismissed all of CVBT/VT's claims against Dan Montano. Our current administration's takeover in 2014 has resulted in CVBT/VT suing Daniel C. Montano 10 different times to stop him from developing FGF-1. Each time CVBT/VT has lost to Daniel C. Montano, resulting in astounding victories for Dan Montano.
CVBT/VT's three biotech experts all independently testified that Dan Montano was innocent from the fraudulent claims made by CVBT/VT management.
The most recent court judgement has not only given Daniel C. Montano the ability to actively pursue the fraudulent claimants in order to satisfy his $1 million dollar judgement, but also has given Dan Montano the ability to actively focus on developing FGF-1 at Zhittya Genesis Medicine which has now initiated two Phase I Clinical Trials in Parkinson's Disease and ALS.
Daniel C. Montano announces that he wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021
Daniel C. Montano announced that he has won a judgement against CVBT/VT
Daniel C. Montano has announced that he has won a $1 million dollar judgement against Cardiovascular Biotherapeutics/Venturis Therapeutics confirmed by the US Federal Court. The judge dismissed all of CVBT/VT's claims against Dan Montano. Our current administration's takeover in 2014 has resulted in CVBT/VT suing Daniel C. Montano 10 different times to stop him from developing FGF-1. Each time CVBT/VT has lost to Daniel C. Montano, resulting in astounding victories for Dan Montano.
CVBT/VT's three biotech experts all independently testified that Dan Montano was innocent from the fraudulent claims made by CVBT/VT management.
The most recent court judgement has not only given Daniel C. Montano the ability to actively pursue the fraudulent claimants in order to satisfy his $1 million dollar judgement, but also has given Dan Montano the ability to actively focus on developing FGF-1 at Zhittya Genesis Medicine which has now initiated two Phase I Clinical Trials in Parkinson's Disease and ALS.
CVBT/VT has lost EVERY lawsuit to Zhittya Genesis Medicine/Zhittya Regenerative Medicine and Daniel C. Montano
Since Dan Montano left the company in 2014 to start Zhittya, our management has consistently attempted to harm the new company. After seven years of lawsuits, all of them have been ruled in favor of Zhittya Genesis as well as their CEO, Dan Montano. The most recent ruling has resulted in a $1 million dollar judgement against CVBT/VT, confirmed by the US Federal Court. This confirmation gives Zhittya and Dan Montano the ability to do a debtors exam in May.
CVBT/Venturis Therapeutics Misconduct results in Dan Montano's $1 million dollar judgement against CVBT/VT
Daniel Montano, founder of CVBT in 1998, left the company in 2014 to found Zhittya Genesis Medicine. CVBT/VT has since filed countless lawsuits, only to lose EVERY SINGLE LAWSUIT to Daniel C. Montano and Zhittya Genesis Medicine. The most recent lawsuit CVBT/Venturis Therapeutics filed against Zhittya Genesis Medicine and Daniel C. Montano has resulted in Zhittya Genesis Medicine being dismissed from the lawsuit, and Daniel Montano having a $1 million dollar judgement against CVBT/VT for their misconduct.
Zhittya Genesis Medicine DISMISSED from CVBT Lawsuit
In a lawsuit Cardiovascular Biotherapeutics filed against Zhittya Genesis Medicine, the Nevada State Court has dismissed Zhittya Genesis Medicine from the lawsuit. The lawsuit had that claimed that Zhittya Genesis Medicine was stealing trade secrets from CVBT which has since been thrown out of court.
The case was easily dismissed after CVBT'S OWN EXPERTS TESTIFIED THAT ZHITTYA GENESIS MEDICINE STOLE NOTHING FROM CVBT.
In a clear victory for Zhittya Genesis Medicine and Dan Montano, whose $1 million dollar judgement against Venturis Therapeutics will likely result in the downfall of CVBT, investors, including myself are wondering if CVBT will make it through 2021.
THE UNITED STATES FEDERAL COURT HAS CONFIRMED DAN MONTANO'S ONE MILLION DOLLAR CLAIM AGAINST CVBT/VENTURIS THERAPEUTICS
Furthermore, with Zhittya Genesis Medicine and Mrs. Montano being ENTIRELY DISMISSED from the lawsuits that Venturis brought fourth there is a clear path for Mr. Daniel Montano to forcibly collect on his 1 million dollar claim. Venturis is at the hands of Dan Montano! Why were we not made aware of this? Why is our administration so quick to announce when lawsuits are filed but not when we are miserably defeated and punished for our defeat?
I worry that Mr. Montano will wipe Venturis off the face of the map with his new ability to forcibly collect on his one million dollar award which has been confirmed by the United States Federal Court.
Debtors Exam for CVBT
Zhittya Genesis Medicine Inc., (formerly known as Zhittya Regenerative Medicine), competitor to Cardiovascular Biotherapeutics Inc., has announced its CEO, Daniel C. Montano, has been awarded an over $1 million legal judgement, confirmed by the US Federal Court, against CVBT and its new name, Venturis Therapeutics.
Mr. Dan Montano is now pursuing the involuntary collections of his judgements against CVBT.
Zhittya Genesis Medicine also announced that ALL legal allegations made against Zhittya Genesis Medicine have been DISMISSED by the judge.
After seven years of lawsuits by CVBT against Zhittya it is clear that CVBT has come out as the ultimate loser after this judgement against them for $1 million. In all this time, CVBT has FAILED TO CONDUCT CLINICAL TRIALS, MANUFACTURE THE DRUG, OR PAID ANY PART OF ITS $30 MILLION IN DELINQUENT BILLS.
Daniel C. Montano wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021.
And that is the bottom line. Funny how no one could dispute my earlier post: Here is a link that is hard to dispute: https://uploads-ssl.webflow.com/5d929ea754fd0f4955087956/608c36b4f0b7c7ffa9bb6319_CAD%20patent%20PR%20final%204.29.2021.pdf
Evidently many are buying into Montano's clones promoting his new company. Hopefully they buy his IPO to satisfy his debt to Venturis.
CEO, Calvin Wallen, has assigned his $2.5 million court judgement to VT which means that VT is now going after Dan Montano for the balance they are owed of $1.7 million. Parents should pay particular attention to the fact that their children could be in pearl due to Conman's proclivity of driving through parking lots full of soccer moms and their kids at 50+ MPH.
Refer to the Worst CEO Ever YT video.
$1,100,000 awarded to Daniel C. Montano by the US Federal Court against CVBT/VT
The United States Federal court has confirmed Daniel C. Montano's $1.1 million dollar judgement against CVBT/VT as a result of their fraudulent and frivolous lawsuit claiming that Daniel C. Montano's IP was not his.
The US Federal Court not only confirmed that Daniel C. Montano has a $1 million dollar (non-off-settable) judgement against CVBT/VT, but that Daniel C. Montano and Zhittya Genesis Medicine own all of their IP.
Daniel C. Montano announces that the US Federal Court has confirmed his IP
The United States Federal Court has confirmed the ruling in favor of Daniel C. Montano citing that Dan Montano owns all of the IP that he and his company, Zhittya Genesis Medicine are developing.
The United States Federal Court's confirmation comes as a result of Cardiovascular Biotherapeutics/ Venturis Therapeutics' own management team testifying in favor of Daniel C. Montano, stating that the IP that Dan Montano and Zhittya Genesis Medicine have been developing are 100% theirs.
Daniel C. Montano Announces His Victory over CVBT/VT
Despite years of fraudulent and frivolous lawsuits it appears that Daniel C. Montano is now victorious over the crooks that run Cardiovascular Biotherapeutics/Venturis Therapeutics.
Daniel C. Montano has been awarded an over $1 million dollar judgment against CVBT/VT as a result of the frivolous lawsuit that they had originally filed.
Daniel C. Montano's more than $1,000,000 dollar judgement against Cardiovascular BioTherapeutics/Venturis Therapeutics has been confirmed by the United States Federal Court System.
Dan Montano's clear victory over CVBT/VT could result in a forced debtors exam against CVBT/VT in order for Montano to collect on his judgement.
How do we invest in Zhittya? Seems to be no replies to any messages to there website. Are they are zombie company as well?
The Big Lie Part 2, the Venturis/CVBT version:
The Venturis Therapeutics/CVBT version of The Big Lie is that there are allegedly two pivotal clinical trials ongoing in coronary artery disease and diabetic foot ulcers.
That's a "PANTS ON FIRE" lie.
Yet this lie is being anonymously promoted publicly by CVBT supporters (who in my opinion are the leadership of this company who are more than happy to lie when their names are kept anonymous, rather than lie to our face using their real name such as "Grant Gordon").
For the record, Venturis/CVBT has not run a single clinical trial since 2007. Not one patient has been treated in nearly 15 years! One cannot be running an ongoing pivotal trial in 2021 if one hasn't run a single clinical trial since 2007.
I issued a public challenge to the liar and coward who anonymously made that absurdly false statement. And so far, the liar/coward has refused to respond.
Here is my question to the liar/coward: Would you please indicate the month and year of the most recent patients treated in these so-called "pivotal trials"? And tell us what hospital(s) they were treated in?
Of course, we will never get a response to this question. Because the honest, correct answer is that there are ZERO ongoing clinical trials, there have been no clinical trials run since 2007, that Venturis Therapeutics is a zombie company that exists only in cyberspace, that Venturis is insolvent, illiquid, and all but dead, that Calvin Wallen and Grant Gordon are con men and liars, and that the so-called "valuable patents" are a pile of steaming sheisse that no one wants or cares about because they're laughably worthless. If these patents are so valuable as is anonymously claimed (and note that claim is never made when someone's name is attached to it), tell us, why has Venturis had them for several years now yet never been able to monetize them in terms of investment, partnering deals, and/or sale of the patents? Easy - because they're a joke and anyone who's actually a biotech person knows that in a nanosecond. The patents tell us what happens in the real world when a failed oil and gas buffoon decides to play biotech.
If Venturis leadership is willing to publicly lie (albeit anonymously) about something so clearly absurd and verifiably untrue as ongoing clinical trials, there's literally nothing they won't lie about. And that's why no investors or partners will ever touch this company--because there's literally nothing that can be trusted, let alone that everything here is worthless.
Soon this zombie company will be put out of all of our misery.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157492465
Followers
|
39
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3648
|
Created
|
04/08/05
|
Type
|
Free
|
Moderators |
VENTURIS THERAPEUTICS (formerly Cardiovascular
Biotherapeutics or CVBT) is a dead, zombie company
that hasn't run a single clinical trial in nearly 15
years. Not even one patient (!) has been treated
since 2007. Venturis Therapeutics is insolvent,
illiquid, and is controlled and run by an individual
who was accused by the U.S government of
embezzling $14 million from his previous company.
Venturis' lawyer, Barry Cannaday of Dentons (one
of the largest law firms in the U.S.), withdrew from
representing Venturis in April 2021 because Dentons
is owed over $200,000 by Venturis, and Mr. Cannaday
attested that "there are currently no assets or
revenue streams" to pay Dentons. Yet anonymous
advocates for Venturis (who I personally believe are
the company's desperate leadership) lie about public
facts that are easily verifiable. One of the most
absurd false claims is that there are (allegedly) two
ongoing pivotal clinical trials (see that particular
false claim below). These "clinical trials" exist only
in cyberspace but not in the real world the rest of us
(including Dentons) live in. That said, enjoy the
entertainment that lies below. Hopefully it gives you
some good laughs - that's about all that's left from
this dead, zombie company. Enjoy!
VENTURIS THERAPEUTICS (VT) OVERVIEW
VT was almost bankrupted by the original
CEO, Daniel C. Montano, and was rescued by
Calvin Wallen, Grant Gordon and then CFO,
Mickael Flaa.
VT had almost $40,000,000 in debt & was
effectively insolvent. The board of directors
who replaced the Dan Montano cronies
rehabilitated VT so that today the company has
almost zero debt and an comprehensive patent
portfolio. Under the disasterous management
of Dan Montano, the company had zero
patents.
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage
biopharmaceutical company advancing novel
therapeutics to address diseases such as
diabetic wounds, severe ischemic heart disease
and
peripheral artery disease. Our pre-clinical
therapeutic programs include erectile
dysfunction,
infarct stroke, degenerative disk disease and
Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on
targeted delivery of next generation
molecules which will improve the quality of life
for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast
Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when
administered to ischemic organs and
tissues. These anatomical targets are shown in
our pipeline section of the website.
www.vt.care
VENTURIS THERAPEUTICS (VT) OVERVIEW
VT was almost bankrupted by the original
CEO, Daniel C. Montano, and was rescued by
Calvin Wallen, Grant Gordon and then CFO,
Mickael Flaa.
VT had almost $40,000,000 in debt & was
effectively insolvent. The board of directors
who replaced the Dan Montano cronies
rehabilitated VT so that today the company has
almost zero debt and an comprehensive patent
portfolio. Under the disasterous management
of Dan Montano, the company had zero
patents.
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage
biopharmaceutical company advancing novel
therapeutics to address diseases such as
diabetic wounds, severe ischemic heart disease
and
peripheral artery disease. Our pre-clinical
therapeutic programs include erectile
dysfunction,
infarct stroke, degenerative disk disease and
Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on
targeted delivery of next generation
molecules which will improve the quality of life
for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast
Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when
administered to ischemic organs and
tissues. These anatomical targets are shown in
our pipeline section of the website.
www.vt.care
VENTURIS THERAPEUTICS OVERVIEW
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage biopharmaceutical company advancing novel
therapeutics to address diseases such as diabetic wounds, severe ischemic heart disease and
peripheral artery disease. Our pre-clinical therapeutic programs include erectile dysfunction,
infarct stroke, degenerative disk disease and Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on targeted delivery of next generation
molecules which will improve the quality of life for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when administered to ischemic organs and
tissues. These anatomical targets are shown in our pipeline section.
vt.care
Venturis Therapeutics (VT) is
a biotechnology company based
in Dallas, Texas. VT has pivotal trials
ongoing in Ischemic Heart Disease &
Diabetic Foot Ulcers.
VT has a comprehensive patent
portfolio protecting its therapeutic
programs.
Venturis Therapeutics (VT) is
a biotechnology company based
in Dallas, Texas. VT has pivotal trials
ongoing in Ischemic Heart Disease &
Diabetic Foot Ulcers.
VT has a comprehensive patent
portfolio protecting its therapeutic
programs.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |